U.S. Military HIV Research Program Clinical Trials Unit expansion
Official title: The Military HIV Research Program (MHRP) Clinical Trial Unit
Funded at Henry M. Jackson Fdn for the Adv Mil/med · NIH-11609389 · Data updated 2026-11-12
A nationwide network of clinical trial sites is being expanded to test HIV prevention and treatment approaches through DAIDS-supported trials.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Henry M. Jackson Fdn for the Adv Mil/med NIH-funded |
| Lab location | 1 site (Bethesda, United States) |
| Project start | December 10, 2013 |
| Project end | November 30, 2027 |
| Funding year | 2026 |
| Award (this year) | $110,741 |
| NIH project number | 3UM1AI108568-13S3 |
| Project ID | NIH-11609389 on NIH RePORTER |
Who could benefit from this research
✓Could help
Individuals at risk for HIV or living with HIV who participate in ongoing or future DAIDS-funded trials at MHRP CTU sites.
✕Less likely to help
Patients not eligible for participating in specific protocols or trial timelines may not benefit directly.
What this research studies
This grant extension builds a larger, multi-site framework for HIV-related clinical trials led by MHRP, with sites in Africa and Asia and a core management team in the U.S. It supports trials across phases, from early safety studies to large efficacy trials, focusing on HIV prevention and treatment in populations with high HIV burden. The effort strengthens collaboration with partners like HVTN, ACTG, and HPTN, and includes a new alliance with IAVI to address TB alongside HIV. The project aims to translate research findings into real-world prevention and care strategies for people living with HIV and those at risk.
Why it matters
Potential benefit: If successful, patients could gain access to more diverse trial locations and faster translation of effective HIV prevention and treatment strategies into care.
How similar studies have gone: Past DAIDS-supported CTUs have facilitated multi-site trials that advance HIV prevention and treatment, showing value in networked, standardized approaches.
Where this research is happening
-
Henry M. Jackson Fdn for the Adv Mil/med
Bethesda, United States Active
Researchers
- Principal investigator: Robb, Merlin L — Henry M. Jackson Fdn for the Adv Mil/med
- Study coordinator: Robb, Merlin L
Related research
Other NIH-funded projects on the same topics.
-
Cooperation partners of SETBP1 in AML development
This grant explores how SETBP1 and AF9 (MLLT3) work together to drive acute myeloid leukemia and whether targeting related epigenetic regulators could help treat aggressive CK-AML.
-
Novel protein biomarkers of chronic pain in adults using a pain registry biobank
A study in adults with chronic pain will look for new protein biomarkers in blood samples to understand better why pain persists and how to improve treatment.
-
Tailored antibody cures for HIV using AI and vaccines
A study to design personalized antibody-based strategies to achieve HIV remission, using lab experiments and computer models to tailor vaccines or antibody treatments to individuals or small groups.
-
Understanding how antibody protection works using 3D protein structures
Researchers will build a 3D-based method to see which viral features relate to prevention by antibodies, using data from people in HIV vaccine and monoclonal antibody trials.
-
Military HIV Clinical Network
This program runs HIV and TB prevention and treatment clinical studies for adults in military-associated and high-HIV-burden communities.
-
Military HIV Clinical Trials Unit
This program runs clinical trials of new HIV vaccines, prevention approaches, and TB treatments for adults at risk of or living with HIV.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.